May 4, 2017 / 8:55 PM / 6 months ago

BRIEF-Five Prime Therapeutics Q1 loss per share $1.21

May 4 (Reuters) - Five Prime Therapeutics Inc

* Five Prime announces first quarter 2017 results and provides business update

* Q1 loss per share $1.21

* Q1 earnings per share view $-1.03 -- Thomson Reuters I/B/E/S

* Five Prime Therapeutics - company estimates ending 2017 with approximately $300 million in cash, cash equivalents and marketable securities Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below